|

CTIM-76 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CTIM-76 Claudin 6 bispecific Antibody

Pipeline

Phase 1: 1

Top Sponsors

  • Context Therapeutics Inc.1

Indications

  • Platinum-resistant Ovarian Cancer1
  • Testicular Cancer1
  • Endometrial Cancer1
  • Cancer1

Little Rock, Arkansas1 trial

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

University of Arkansas Winthrop P. Rockefeller Cancer Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.